Application of an iPSC‐Derived Organoid Model for Localized Scleroderma Therapy

Localized scleroderma (LoS) is a rare chronic disease with extensive tissue fibrosis, inflammatory infiltration, microvascular alterations, and epidermal appendage lesions. However, a deeper understanding of the pathogenesis and treatment strategies of LoS is currently limited. In the present work,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Jie, Li, Wei, Cao, Ruiyuan, Gao, Dunqin, Zhang, Qiyu, Li, Xiao, Li, Biyou, Lv, Luye, Li, Mansheng, Jiang, Junyi, Wang, Yujie, Li, Jun, Wu, Zhihong, Zhu, Yunping, Zhong, Wu, Zhang, Shuyang, Leng, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165518/
https://www.ncbi.nlm.nih.gov/pubmed/35315234
http://dx.doi.org/10.1002/advs.202106075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165518/
https://www.ncbi.nlm.nih.gov/pubmed/35315234
http://dx.doi.org/10.1002/advs.202106075

Ejemplares similares